IYH Holdings — iShares U.S. Healthcare ETF
All 106 reported holdings of iShares U.S. Healthcare ETF (IYH) by percentage of net assets, from the fund's latest SEC N-PORT filing.
| Holding | % of net assets | Value (USD) |
|---|---|---|
| Eli Lilly And Company | 13.72% | $384.59M |
| Johnson & Johnson | 10.14% | $284.11M |
| Abbvie Inc. | 6.86% | $192.29M |
| Unitedhealth Group Incorporated | 6.18% | $173.17M |
| Merck & Co., Inc. | 4.97% | $139.37M |
| Amgen Inc. | 3.41% | $95.66M |
| Thermo Fisher Scientific Incorporated | 3.32% | $92.91M |
| Gilead Sciences, Inc. | 2.99% | $83.70M |
| Intuitive Surgical, Inc. | 2.96% | $82.97M |
| Abbott Laboratories | 2.88% | $80.75M |
| Pfizer Inc. | 2.78% | $77.91M |
| Bristol-Myers Squibb Company | 2.26% | $63.42M |
| Danaher Corporation | 2.07% | $57.88M |
| Stryker Corporation | 1.99% | $55.72M |
| Vertex Pharmaceuticals Incorporated | 1.99% | $55.71M |
| Medtronic Public Limited Company | 1.90% | $53.33M |
| Boston Scientific Corporation | 1.56% | $43.68M |
| Elevance Health, Inc. | 1.53% | $43.01M |
| The Cigna Group | 1.40% | $39.32M |
| Regeneron Pharmaceuticals, Inc. | 1.32% | $36.85M |
| Hca Healthcare, Inc. | 1.29% | $36.17M |
| Zoetis Inc. | 0.93% | $26.03M |
| Edwards Lifesciences Corporation | 0.88% | $24.69M |
| Cardinal Health, Inc. | 0.84% | $23.64M |
| Idexx Laboratories, Inc. | 0.82% | $22.94M |
| Becton, Dickinson And Company | 0.78% | $21.90M |
| Alnylam Pharmaceuticals, Inc. | 0.72% | $20.15M |
| BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares | 0.69% | $19.24M |
| Agilent Technologies, Inc. | 0.60% | $16.91M |
| Resmed Inc. | 0.57% | $16.03M |
| Waters Corporation | 0.56% | $15.61M |
| Insmed Incorporated | 0.52% | $14.66M |
| Humana Inc. | 0.52% | $14.66M |
| Ge Healthcare Technologies Inc. | 0.51% | $14.30M |
| Biogen Inc. | 0.51% | $14.20M |
| Natera, Inc. | 0.50% | $13.99M |
| Iqvia Holdings, Inc. | 0.49% | $13.74M |
| Centene Corporation | 0.48% | $13.52M |
| Revolution Medicines, Inc. | 0.47% | $13.27M |
| United Therapeutics Corporation | 0.44% | $12.44M |
| Dexcom, Inc. | 0.43% | $11.96M |
| Veeva Systems Inc. | 0.43% | $11.95M |
| Quest Diagnostics Incorporated | 0.40% | $11.12M |
| Labcorp Holdings Inc. | 0.39% | $11.02M |
| West Pharmaceutical Services, Inc. | 0.39% | $10.94M |
| Steris Public Limited Company | 0.39% | $10.94M |
| Illumina, Inc. | 0.36% | $10.00M |
| Royalty Pharma PLC | 0.35% | $9.89M |
| Viatris Inc. | 0.32% | $8.86M |
| Moderna, Inc. | 0.30% | $8.46M |
| Zimmer Biomet Holdings, Inc. | 0.30% | $8.39M |
| Tenet Healthcare Corporation | 0.28% | $7.92M |
| Incyte Corporation | 0.28% | $7.87M |
| Medline Inc. | 0.26% | $7.40M |
| Neurocrine Biosciences, Inc. | 0.23% | $6.56M |
| Penumbra, Inc. | 0.23% | $6.37M |
| The Cooper Companies, Inc. | 0.23% | $6.31M |
| Roivant Sciences Ltd | 0.22% | $6.21M |
| Insulet Corporation | 0.22% | $6.21M |
| Ionis Pharmaceuticals, Inc. | 0.22% | $6.07M |
| Jazz Pharmaceuticals Public Limited Company | 0.22% | $6.06M |
| Align Technology, Inc. | 0.22% | $6.06M |
| Exelixis, Inc. | 0.21% | $6.00M |
| Elanco Animal Health Incorporated | 0.20% | $5.66M |
| Biomarin Pharmaceutical Inc. | 0.19% | $5.25M |
| Globus Medical, Inc. | 0.19% | $5.19M |
| Encompass Health Corporation | 0.18% | $5.12M |
| Solventum Corporation | 0.18% | $5.10M |
| Molina Healthcare, Inc. | 0.18% | $5.07M |
| Revvity, Inc. | 0.18% | $5.04M |
| Medpace Holdings, Inc. | 0.17% | $4.80M |
| Baxter International Inc. | 0.17% | $4.64M |
| Universal Health Services, Inc. | 0.16% | $4.53M |
| Bio-Techne Corporation | 0.16% | $4.40M |
| Charles River Laboratories International, Inc. | 0.15% | $4.18M |
| Masimo Corporation | 0.15% | $4.13M |
| Henry Schein, Inc. | 0.14% | $3.89M |
| Halozyme Therapeutics, Inc. | 0.14% | $3.80M |
| Qiagen N.V. | 0.13% | $3.59M |
| Repligen Corporation | 0.11% | $3.19M |
| Chemed Corporation | 0.11% | $3.03M |
| Tempus Ai, Inc. | 0.10% | $2.83M |
| Teleflex Incorporated | 0.10% | $2.82M |
| Davita Inc. | 0.10% | $2.81M |
| BlackRock Funds III: BlackRock Cash Funds: Treasury; SL Agency Shares | 0.10% | $2.76M |
| Avantor, Inc. | 0.10% | $2.76M |
| Bio-Rad Laboratories, Inc. | 0.09% | $2.65M |
| Apellis Pharmaceuticals, Inc. | 0.08% | $2.27M |
| Corcept Therapeutics Incorporated | 0.08% | $2.26M |
| Envista Holdings Corporation | 0.08% | $2.16M |
| Bruker Corporation | 0.07% | $1.96M |
| Sotera Health Company | 0.07% | $1.95M |
| Organon & Co. | 0.06% | $1.78M |
| Viking Therapeutics Inc | 0.06% | $1.76M |
| Doximity Inc | 0.06% | $1.66M |
| Summit Therapeutics Inc | 0.05% | $1.28M |
| Dentsply Sirona Inc. | 0.04% | $1.20M |
| Acadia Healthcare Company, Inc. | 0.04% | $1.20M |
| Ultragenyx Pharmaceutical Inc | 0.04% | $1.16M |
| Sarepta Therapeutics, Inc. | 0.04% | $1.05M |
| Caris Life Sciences, Inc. | 0.03% | $884.43K |
| Inspire Medical Systems Inc | 0.03% | $820.37K |
| Perrigo Company Public Limited Company | 0.03% | $819.08K |
| Certara, Inc. | 0.01% | $380.92K |
| Hologic, Inc. Cvr | 0.00% | $1.17K |
| Xav Health Care Jun26 | -0.00% | $-121.80K |